NFκB is a well-established master regulator of apoptosis in tumor cells, and overwhelming inflammation associated with aberrant NFκB is linked to carcinogenesis, tumor progression, and therapy resistance [102]. The gene discussed is NFKB1; the disease is neoplasm.